Skip to content

Author

Saravanan Ravindran

We have 5 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

ANALYTICAL QUALITY BY DESIGN-ASSISTED DEVELOPMENT AND VALIDATION OF A RAPID STABILITY-INDICATING GRADIENT ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR SIMULTANEOUS ESTIMATION OF EMPAGLIFLOZIN, SACUBITRIL, AND VALSARTAN IN PHARMACEUTICAL DOSAGE FORMS

Objectives: Simultaneous estimation of empagliflozin, sacubitril, and valsartan in combined pharmaceutical formulations is analytically challenging due to their differing polarity, physicochemical properties, and chromatographic retention behavior. Conventional high-performance liquid chromatography methods often requi...

B. Sireesha, Saravanan Ravindran · 0 citations
Review Open access Sep 2026

CARBON AND ENZYME-BASED NANOBUD FOR ENVIRONMENTAL SUSTAINABILITY IN PHARMACEUTICAL WASTEWATER TREATMENT

Compared with conventional adsorbents and other nanomaterials, nanobuds exhibit higher adsorption capacities, improved catalytic activity, and satisfactory regeneration and reuse potential, despite challenges related to synthesis cost, scalability, catalyst leaching, and potential environmental toxicity.

Chaithanya ap, Saravanan Ravindran, Sebastin Varghese · 0 citations
Open access Sep 2026

Synergistic Oxygen and Nitric Oxide Delivery Via an Immuno Instructive Silk Fibroin Hydrogel for Chronic Diabetic Wound Repair

The dual gas-releasing silk fibroin hydrogel effectively restores the diabetic wound microenvironment and represents a promising translational strategy for advanced chronic diabetic wound management.

Murali Krishnan M. P., Saravanan Ravindran, Rajaganapathy Kaliyaperumal · 0 citations
Review

Emerging Role of Human Organoids in Drug Discovery and Development: Current Advances and Challenges

Overall, organoid technology represents a promising approach for precision medicine, personalized therapy, and next-generation drug development and continued development of standardized culture systems and multicellular organoid platforms may improve reproducibility and regulatory acceptance.

B. Sireesha, S. Meharaj, Saravanan Ravindran · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.